EN
HI
Suven Life Sciences share price chart
Suven Life Sciences Share Key Metrics
Volume
1.01 L
Market Cap
8171.38 CR
LTQ@LTP
20@309.00
ATP
311.55
Var Margin
100 %
Circuit Range
247.9-371.8
Delivery %
37.03 %
Value
3.14 CR
ASM/GSM
No
Market Lot
1
Summary
SUVEN stock price is ₹309 as of 5 Aug, 2026. The stock intraday movement has stayed between ₹308.95 and ₹315.45, while Suven Life Sciences share price 52 week high low is ₹124.11 & ₹371.00.
In terms of trading activity, SUVEN share price has recorded a volume of 1,00,905 shares. The Suven Life Sciences has a market cap of ₹263720583. The stock’s Average Traded Price (ATP) stands at ₹311.55, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 20 @ ₹309.00.
The Suven Life Sciences upper circuit limit is ₹371.80 & The Suven Life Sciences lower circuit limit is ₹247.90, with a Value of ₹3.14 CR. The Delivery Percentage for the day is 37.03%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Suven Life Sciences Fundamentals
P/E Ratio
0
P/B Ratio
12.81
Div. Yield
0
Sector P/E
64.89
Sector P/B
3.24
Sec. Div. Yield
0.52
Suven Life Sciences Resistance and Support
Pivot 308.28
Resistance
First Resistance
316.56
Second Resistance
323.28
Third Resistance
331.56
Support
First Support
301.56
Second Support
293.28
Third Support
286.56
Suven Life Sciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 05 2026 | 311.45 | 309 | -0.27% | 315.45 | 308.95 |
| Tue Aug 04 2026 | 307.95 | 309.85 | 0.86% | 315 | 300 |
| Mon Aug 03 2026 | 307.25 | 307.2 | 0.03% | 313.39 | 304 |
Suven Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-13 | Audited Results |
| 2026-01-29 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-05-13 | Audited Results & Preferential issue |
| 2025-01-24 | Quarterly Results |
| 2024-10-29 | Quarterly Results |
| 2024-08-05 | Quarterly Results |
Suven Life Sciences News
Suven Life Sciences Ltd - 530239 - Board Meeting Intimation for Consideration Of Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June, 2026
Suven Life Sciences' Board will meet on August 6, 2026, to review and approve the un-audited financial results for the quarter ended June 30, 2026. This meeting will finalize the company's first-quarter performance.
Jul 30 2026 15:35:12
Suven Life Sciences Ltd - 530239 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Jasti Property and Equity Holdings Private Limited's stake in Suven Life Sciences diluted to 65.47% from 70.15%. This dilution occurred due to the allotment of 2.71 lakh ESOP shares and 1.85 crore shares from warrant conversions to non-promoters.
Jul 20 2026 19:35:50
Read More
Suven Life Sciences Management
| Name | Position |
|---|---|
| Venkateswarlu Jasti | Chairman & Managing Director |
| Seyed E Hasnain | Non Executive Director |
Suven Life Sciences Similar Stocks
Jupiter Life Line Hospitals Ltd.
318.10
-3.45 (1.07%)
Healthcare Global Enterprises Ltd.
674.05
1.80 (0.27%)
Sudeep Pharma Ltd.
882.75
10.95 (1.26%)
Strides Pharma Science Ltd.
967.70
-26.90 (2.70%)
Thyrocare Technologies Ltd.
610.80
6.15 (1.02%)
Procter & Gamble Health Ltd.
6456.50
-26.00 (0.40%)
Yatharth Hospital & Trauma Care Services Ltd.
853.80
8.30 (0.98%)
Sanofi India Ltd.
3329.70
-64.60 (1.90%)
Nephrocare Health Services Ltd.
710.30
-2.85 (0.40%)
Suven Life Sciences FAQs
The Buying Price of Suven Life Sciences share is 309 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Suven Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Suven Life Sciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Suven Life Sciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Suven Life Sciences shares is 12.81. Useful to assess the stock's value relative to its book value.
To assess Suven Life Sciences’s valuation compare Sector P/E, P/B which are 64.89 & 3.24 with sector averages, along with growth rates and financial metrics.
The Market Cap of Suven Life Sciences is 8171.38 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Suven Life Sciences share price is 371.00 & 124.11. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Suven Life Sciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
